Amphotericin-B entrapped lecithin/chitosan nanoparticles for prolonged ocular application.
Yashpal S Chhonker, Yarra Durga Prasad, Hardik Chandasana, Akhilesh Vishvkarma, Kalyan Mitra, Praveen K Shukla, Rabi S Bhatta
Index: Int. J. Biol. Macromol. 72 , 1451-8, (2014)
Full Text: HTML
Abstract
Fungal keratitis is the major cause of vision loss worldwide. Amphotericin-B is considered as the drug of choice for fungal infections. However, its use in ophthalmic drug delivery is limited by the low precorneal residence at ocular surface as a result of blinking reflex, tear turnover and nasopharyngeal drainage. We report Amphotericin-B loaded lecithin/chitosan nanoparticles for prolonged ocular application. The prepared nanoparticles were in the size range of 161.9-230.5 nm, entrapment efficiency of 70-75%, theoretical drug loading of 5.71% with positive zeta potential of 26.6-38.3 mV. As demonstrated by antifungal susceptibility against Candida albicans and Aspergillus fumigatus, nanoparticles were more effective than marketed formulation. They exhibited pronounced mucoadhesive properties. In-vivo pharmacokinetic studies in New Zealand albino rabbit eyes indicated improved bioavailablity (∼ 2.04 fold) and precorneal residence time (∼ 3.36 fold) by nanoparticles prepared from low molecular weight chitosan as compared with marketed formulation.Copyright © 2014. Published by Elsevier B.V.
Related Compounds
Related Articles:
Aptamer-based polyvalent ligands for regulated cell attachment on the hydrogel surface.
2015-04-13
[Biomacromolecules 16(4) , 1382-9, (2015)]
Bacteriophage PBC1 and its endolysin as an antimicrobial agent against Bacillus cereus.
2015-04-01
[Appl. Environ. Microbiol. 81(7) , 2274-83, (2015)]
H4 histamine receptors inhibit steroidogenesis and proliferation in Leydig cells.
2014-12-01
[J. Endocrinol. 223(3) , 241-53, (2014)]
2014-12-29
[Small 10(24) , 5126-36, (2014)]
2014-10-01
[Biochim. Biophys. Acta 1851(2) , 152-62, (2015)]